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Dear Sir, 
Myotonia congenita is a non-dystrophic muscular dis- 
ease characterized by impaired muscle relaxation after 
voluntary or evoked contraction and muscle stiffness. 
Myotonia typically occurs after a period of rest and 
decreases after repetitive movement, the so-called warm-up 
phenomenon [1]. Muscular hypertrophy is an- other 
important clinical sign. 
Myotonia congenita, both in dominant (Thomsen dis- 
ease) and in recessive form (Becker disease), is caused 
by mutations in the CLCN1 gene that encodes the major 
skeletal muscle chloride channel [2]. Dysfunction of this 
channel causes hyperexcitability of the skeletal muscle 
membrane and repetitive firing of muscle action poten- 
tials [3]. More than 150 CLCN1 pathogenic variants  
have been identified. 
We present an Italian family with Thomsen myotonia 
(Fig. 1) in which a novel mutation in the CLCN1  gene 
was detected. 
A 60-year-old man (patient II:1) complained from 
childhood of transient stiffness and weakness that im- 
proved with activity and got worse with cold tempera- 
tures. Neurological examination revealed generalized 
muscle hypertrophy, most prominent in quadriceps and 
gastrocnemius muscles, with normal strength.  Grip  and 
lip myotonia were evident. Percussion of the thenar 
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eminence elicited brief opposition. CPK were  360  U/L 
(nv 60-190). EMG revealed profuse myotonic discharges 
in all examined muscles with normal motor unit 
potentials. 
The 32-year-old firstborn son (patient III:1) presented 
the same symptoms of the father from infancy. 
Neurological examination showed Hercules-like appear- 
ance. Myotonia was present in all four  limbs  and  in 
facial muscles including lids. Percussion of the thenar 
eminence elicited brief opposition. CPK were 420 U/L. 
EMG showed abundant myotonic discharges  in  all  test- 
ed muscles and mild myopathic changes  in  iliopsoas  and 
deltoids muscles. 
In both patients Mexiletine 200 mg bid was started with 
improvement. 
After genetic counseling, probands and their familiars 
underwent to the screening for CLCN1 gene. Sequence 
analysis evidenced the previously reported p.Phe167Leu on 
exon 4, and the nucleotide change c.645G>T on exon 5 
leading to the missense p.Lys215Asn (Fig. 2). This var- 
iant was unreported; therefore, 160 control alleles were 
checked for this novel variant, and none resulted positive. 
The possible pathological meaning of the variant was eval- 
uated by in silico tools (PROVEAN provean.jcvi.org; 
MutationTaster www.mutationtaster.org; MutPred mutpred. 
mutdb.org) and was unanimously predicted as pathogenic. 
Subjects II:1 and III:2 were heterozygous for p.Lys215Asn; 
II:2 carried p.Phe167Leu, III:1 was a compound heterozygote 
of both mutations. 
Thereupon, we clinically evaluated subject III:2, who 
did not complain any symptoms. Neurological examina- 
tion revealed only generalized muscle hypertrophy. CPK 
were normal. EMG showed myotonic discharges of 
proximal and distal muscles but not at masseter. 
Mutations in CLCN1 gene are causative of congenital 
myotonia. We report a novel mutation in a  family with 
two males suffering from myotonia congenita and one 
Fig. 1 Family pedigree 
asymptomatic carrier. Serendipitously, the wife presented 
a known mutation, transmitted to the symptomatic son. 
Subject III:2 probably represents a subclinical variant of 
Thomsen disease. In fact, heterozygotes for CLCN1 mu- 
tation are often asymptomatic, and mild myotonia is 
revealed only by physical examination, but some  sub-  
jects presented pronounced myotonia [4]. Several muta- 
tions behave as partially dominant with a reduced pen- 
etrance, and mutations in CLCNl gene  do not necessar-   
ily have a classic Mendelian pattern [5]. 
Lysin 215 lies in the E domain of the channel, embedded in 
the membrane, though this residue seems to be far from 
the one (Glu 232) catching chloride ions in the 
protopore. p.Lys215Asn is likely a dominant mutation 
without complete penetrance. Other dominant mutations 
with reduced penetrance are described before,  suggest-  
ing a strong influence of other unclear genetic factors [4–
6]. 
Several studies reported that Phe167Leu mutation has 
very mild effects, and the clinical signs of the pathology 
have mostly been attributed to compound heterozygosis 
with other mutations [7]. It is likely that in our patient 
with double mutation, the Phe167Leu mutation 
strengthens the symptomatology through a gene dosage 
effect due to the presence of a  second  mutation  with 
more severe phenotype. 
Fig. 2 Electropherogram showing the heterozygous nucleotide change 
c.645G>T on exon 5 in CLCN1 gene, leading to the missense
p.Lys215Asn
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